Results Snapshot
Figures in Million
Consolidate Annual Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Sep'18
Net Sales
3.55
240.74
243.23
138.29
87.99
168.80
16.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3.55
240.74
243.23
138.29
87.99
168.80
16.14
Raw Material Cost
18.59
12.49
10.42
0.00
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
197.97
174.80
189.47
130.53
81.46
36.73
28.01
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
32.35
18.33
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
96.82
90.93
122.82
80.08
51.66
26.54
19.08
Other Expenses
25.89
14.92
9.90
6.84
4.21
3.99
2.03
Total Expenditure (Excl Depreciation)
604.63
445.74
421.74
279.06
175.21
103.17
67.38
Operating Profit (PBDIT) excl Other Income
-601.1
-205
-178.5
-140.8
-87.2
65.6
-51.2
Other Income
20.97
16.84
5.80
8.19
8.61
6.96
1.06
Operating Profit (PBDIT)
-561.51
-175.67
-162.29
-132.58
-78.61
72.59
-50.18
Interest
32.35
18.33
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.43
Gross Profit (PBDT)
-15.04
228.24
232.81
0.00
0.00
0.00
0.00
Depreciation
18.59
12.49
10.42
8.27
5.94
4.44
4.70
Profit Before Tax
-612.46
-206.49
-172.71
-140.85
-84.55
68.15
-54.45
Tax
-2.77
2.78
3.79
0.00
0.00
0.17
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-599.49
-205.28
-176.06
-140.85
-84.55
67.97
-54.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-599.49
-205.28
-176.06
-140.85
-84.55
67.97
-54.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-10.20
-4.00
-0.43
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-609.69
-209.28
-176.49
-140.85
-84.55
67.97
-54.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
185.44
271.34
398.52
408.82
461.78
244.59
95.80
Earnings per share (EPS)
-5.0
-1.92
-1.67
-1.36
-0.84
0.69
-0.65
Diluted Earnings per share
-5.0
-1.92
-1.67
-1.36
-0.84
0.69
-0.65
Operating Profit Margin (Excl OI)
-16927.06%
-85.16%
-73.39%
-107.77%
-105.87%
36.25%
-346.52%
Gross Profit Margin
-16723.88%
-80.59%
-66.72%
-95.87%
-89.34%
43.0%
-308.19%
PAT Margin
-16882.37%
-85.27%
-72.39%
-101.85%
-96.09%
40.27%
-337.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Sep 2024 is -98.50% vs -1.03% in Sep 2023
Consolidate Net Profit
YoY Growth in year ended Sep 2024 is -191.30% vs -18.58% in Sep 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Sep 2024 is -202.60% vs -14.52% in Sep 2023
Interest
YoY Growth in year ended Sep 2024 is 77.05% vs 0.00% in Sep 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Sep 2024 has fallen from Sep 2023
Compare Annual Results Of Arrowhead Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
3.55
12.44
-8.89
-71.46%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3.55
12.44
-8.89
-71.46%
Raw Material Cost
18.59
3.53
15.06
426.63%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
197.97
0.00
197.97
Power Cost
0
0
0.00
Manufacturing Expenses
32.35
0.00
32.35
Selling and Distribution Expenses
96.82
239.80
-142.98
-59.62%
Other Expenses
25.89
52.87
-26.98
-51.03%
Total Expenditure (Excl Depreciation)
604.63
772.03
-167.40
-21.68%
Operating Profit (PBDIT) excl Other Income
-601.08
-759.59
158.51
20.87%
Other Income
20.97
19.23
1.74
9.05%
Operating Profit (PBDIT)
-561.51
-737.43
175.92
23.86%
Interest
32.35
0.00
32.35
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
-15.04
8.91
-23.95
-268.80%
Depreciation
18.59
2.93
15.66
534.47%
Profit Before Tax
-612.46
-740.36
127.90
17.28%
Tax
-2.77
0.51
-3.28
-643.14%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
-599.49
-740.87
141.38
19.08%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-599.49
-740.87
141.38
19.08%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
-10.20
0.00
-10.20
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-609.69
-740.87
131.18
17.71%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
185.44
996.52
-811.08
-81.39%
Earnings per share (EPS)
-5.00
-13.18
8.18
62.06%
Diluted Earnings per share
-5.00
-13.18
8.18
62.06%
Operating Profit Margin (Excl OI)
-16,927.06%
-6,107.98%
0.00
-10,819.08%
Gross Profit Margin
-16,723.88%
-5,929.80%
0.00
-10,794.08%
PAT Margin
-16,882.37%
-5,957.44%
0.00
-10,924.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 0.36 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is -98.50% vs -1.03% in Sep 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -60.97 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is -191.30% vs -18.58% in Sep 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -58.25 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is -202.60% vs -14.52% in Sep 2023
Annual - Interest
Interest 3.24 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is 77.05% vs 0.00% in Sep 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -16,927.06%
in Sep 2024Figures in %
YoY Growth in year ended Sep 2024 has fallen from Sep 2023






